key: cord-0980467-7gqzyzjz authors: Tamimi, Faleh; Abusamak, Mohammad; Akkanti, Bindu; Chen, Zheng; Yoo, Seung‐Hee; Karmouty‐Quintana, Harry title: The case for Chronotherapy in COVID‐19 induced Acute Respiratory Distress Syndrome (ARDS). date: 2020-05-22 journal: Br J Pharmacol DOI: 10.1111/bph.15140 sha: 896591650b7cd9bb68fe93a5463067ca68e61a59 doc_id: 980467 cord_uid: 7gqzyzjz COVID‐19, the disease resulting from infection by a novel coronavirus: SARS‐Cov2 that has rapidly spread since November 2019 leading to a global pandemic. SARS‐Cov2 has infected over 4 million people and caused over 290,000 deaths worldwide. Although most cases are mild, a subset of patients develop a severe and atypical presentation of Acute Respiratory Distress Syndrome (ARDS) that is characterised by a cytokine release storm (CRS). Paradoxically, treatment with anti‐inflammatory agents and immune regulators has been associated with worsening of ARDS. We hypothesize that the intrinsic circadian clock of the lung and the immune system may regulate individual components of CRS and thus chronotherapy may be used to effectively manage ARDS in COVID‐19 patients. Since December 2019, SARS-Cov2 has spread rapidly leading to a global pandemic of COVID-19 (Guo et al., 2020) . Although COVID-19 is mild in the majority of cases, a subset of patients quickly develop acute respiratory distress syndrome (ARDS), a clinical presentation of acute lung injury (ALI), that leads to respiratory failure requiring mechanical ventilation (Fung, Yuen, Ye, Chan & Jin, 2020) . This unprecedented crisis is equal only in magnitude to the 1918 influenza pandemic (Taubenberger & Morens, 2006) . Regrettably, despite important medical and technological advancements since then, our approach to treating patients with acute lung injury following influenza or SARS-Cov2 infection remain palliative at best, with no proven pharmacological therapies (Mehta, McAuley, Brown, Sanchez, Tattersall & Manson, 2020) . A central challenge for the development of therapies that target ARDS is the myriad of proinflammatory mediators that are released during ARDS (Conti et al., 2020) . This response in COVID-19-induced ARDS has been termed as a cytokine release storm (CRS) (Mehta, McAuley, Brown, Sanchez, Tattersall & Manson, 2020; Ruan, Yang, Wang, Jiang & Song, 2020) . The CRS seen in severe cases of COVID-19 include high numbers neutrophils and low levels of lymphocytes, as well as elevated serum levels of interleukin ( IL)-1β, IL-2, IL-6, IL-8, IL-9, IL-10, IL-17, G-CSF, GM-CSF, IFNγ, TNFα, IP10, and MCP1 (Huang et al., 2020; Ruan, Yang, Wang, Jiang & Song, 2020) . Thus, understanding the mechanisms that modulate the release of these pro-inflammatory mediators in ALI is paramount to developing effective strategies to treat ARDS. There is an outstanding paradox that COVID-19 causes a CRS that is associated with increased lethality. Yet, reports suggest that anti-inflammatory drugs such as ibuprofen could aggravate the progression of disease. Further, recent studies in respiratory infections have shown that while anti-inflammatory agents could alleviate symptoms, they can also promote increased viral shedding (Walsh et al., 2016) . Even though this possibility has not been confirmed with COVID-19, it is very plausible that this is the reason why NSAIDS could be detrimental. In this sense, ideal management of COVID-19 would entail a reduction of harmful inflammatory mediators that damage the host but maintain expression of key mediators that target the virus. An emerging venue of therapeutic development impinges on the circadian clock, the biological timer that has been shown to control the rhythmic expression and release of many cytokines in inflammatory settings (Labrecque & Cermakian, 2015; Thompson, Walmsley & Whyte, 2014) . However, despite the known effects of the circadian clock in lung diseases such as asthma (Clark, 1987) , how the circadian clock influences the progression of ALI remains largely unknown. Studying the circadian rhythm of lung injury secondary to ventilation therapy (Ventilator induced lung injury, VILI) is a current concern for COVID-19. Circadian rhythm disruption was seen in a rat model of VILI with high and low tidal volumes by studying the expression of Bmal1, clock, Per2 and REV-ERBα mRNA expression. REV-ERBα was found to have an important role in VILI and inflammation. That is, circadian rhythm disorder in inflammation response may be a novel pathogenesis of VILI (Li, Wang, Hu & Tan, 2013) . Club cells have been also found to have a role in lungs circadian rhythm. Selective ablation of these cells resulted in the loss of circadian rhythm in lung slices, further demonstrating the importance of this cell type in maintaining pulmonary circadian rhythm in one murine and human lung tissue study (Gibbs et al., 2009 ) . The immune system displays circadian rhythms, for instance at the beginning of daily activity there is increased expression of pro-inflammatory mediators such as IL-1β, IL-6, IL-12,TLR9 and TLR4, CCL2, CXCL1, CCL5, as well as macrophage and leukocyte activity, which leads to potential damage in injured tissues. By contrast, anti-inflammatory mediators and other growth or angiogenesis factors, such as the vascular endothelial growth factor (VEGF), peak during the resting phase ( The lungs also have an intrinsic circadian clock which plays a key role in inflammation and leukocyte migration in the lungs, as well as in many lung diseases including viral pneumonia (Nosal, Ehlers & Haspel, 2019; Sundar, Yao, Sellix & Rahman, 2015) . Circadian rhythms in viral respiratory illness have been so far examined in mice for parainfluenza and influenza A viruses (IAV), which cause bronchiolitis, and pneumonia in humans respectively. With either virus, acute inflammatory responses, but not the peak viral load, vary with the time of inoculation in wild-type mice (Ehlers et al., 2018; Sengupta et al., 2019) . Similarly, deletion of the clock gene Bmal1 worsens acute lung injury and lung inflammation in response to parainfluenza or IAV, suggesting that circadian clocks may play a role (immunologic or otherwise) in the resolution of viral pneumonia. Additionally, there is strong evidence from animal models that the circadian regulation within the lung is important in the likelihood of developing chronic lung disease such as pulmonary fibrosis in the aftermath of the infections. A key regulator of the circadian clock is the hypothalamic-pituitary-adrenal (HPA) axis (Tsang, Astiz, Friedrichs & Oster, 2016) . The suprachiasmatic nuclei (SCN) neurons in the hypothalamus is the central clock that modulates the peripheral clocks via the HPA axis, through the adrenocorticotropic hormone (ACTH), the sympathetic nervous system (SNS), and the subsequent rhythmic release of hormones (glucocorticoids, epinephrine and norepinephrine) from the adrenal glands. This ultimately regulates the rhythm of the internal clocks genes found in each cell such as Bmal1 and Per2 (Scheiermann, Kunisaki & Frenette, 2013 ). Interestingly, autopsies from patients who died in the SARS epidemic of 2003, revealed the presence of SARS-Cov in the adrenal glands concomitant with degeneration and necrosis (Pal, 2020) . Further, SARS-Cov expresses amino acid sequences with homology to the host ACTH hormone (Wheatland, 2004) . Thus, antibodies produced by the host to target the virus may also attack the host ACTH, resulting in cortisol insufficiency (Wheatland, 2004) . Also, a potential mechanism that results in dysregulation of the circadian clock following SARS-Cov2 infection may be through its effect on dampening the HPA axis and ACTH (Pal, 2020) as well clock gene alterations due to mechanical ventilation (Li, Wang, Hu & Tan, 2013) . Present studies are underway to measure serum cortisol and ACTH levels that will help elucidate the mechanisms leading to circadian clock dysfunction in severe COVID-19 cases (Pal, 2020) . instance, infections at the beginning of the activity phase are more fatal than infections that occur at the beginning of the resting phase (Sengupta et al., 2019) . Evidence indicates an essential role of the circadian rhythm of NK cells underlying this temporal pattern. These temporal patterns may have important implications for shift workers, where ablated cortisol levels (Kudielka, Buchtal, Uhde & Wust, 2007) and higher incidences of cardiovascular complications are reported (Vyas et al., 2012) . Therefore COVID 19 (IL-1 β, IL-8, IL-10R, IL-6R, and TNFα) , as well as the activity of immune cells involved in the anti-viral immune response ( CD 8, NK and B cells) . Based on the known circadian peak (point of culmination of an oscillatory function) and circadian through (lowest value of an oscillatory function) for known detrimental ( Table 1) or beneficial ( Table 2 ) inflammatory mediators identified in COVID-19 patients, treatment could be optimized for chronotherapy. Chronotherapy include both chronopharmacokinects and chronopharmacodynamics where circadian oscillations in the expression levels of the drug and target are taken into consideration to maximize drug efficacy (Levi & Schibler, 2007) . Hereby, adjusting the timing of the day in which the medications are given to result in highest drug levels at the time point when detrimental inflammatory mediators reach their Peak (Figure 1 ). This would mean that afternoon is the preferred time window for drug administration whereas nighttime intake should be avoided. This is particularly important when administering immune-modulators where a single dose is usually given. Furthermore, the goal of chronotherapy in COVID-19, is to avoid reaching steady-state drug levels, as in the case of anti-inflammatory therapy, these would dampen the inflammatory response directed towards the virus. *involved both in the "cytokine storm" and in the anti-viral response This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved. Chronotherapy of Non-Steroidal Anti-Inflammatory Drugs May Enhance Postoperative Recovery Circadian clocks in mouse and human CD4+ T cells Effects of sleep and circadian rhythm on human circulating immune cells Characterization of lung inflammation and its impact on macrophage function in aging Diurnal rhythm of asthma Induction of proinflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies Circadian clock proteins and immunity Cortisol and epinephrine control opposing circadian rhythms in T cell subsets BMAL1 links the circadian clock to viral airway pathology and asthma phenotypes The expression of cytokine activity by fracture callus A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses Circadian timing in the lung; a specific role for bronchiolar epithelial cells The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Clinical features of patients infected with 2019 novel coronavirus in Wuhan Circadian variation of granulocyte colony stimulating factor levels in man A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells Circadian cortisol profiles and psychological selfreports in shift workers with and without recent change in the shift rotation system Circadian Clocks in the Immune System COVID-19: protecting health-care workers Circadian rhythms: mechanisms and therapeutic implications A study on circadian rhythm disorder of rat lung tissue caused by mechanical ventilation induced lung injury The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock Chronic shiftlag alters the circadian clock of NK cells and promotes lung cancer growth in rats COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet Inhibition of IgEmediated allergic reactions by pharmacologically targeting the circadian clock The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways Why Lungs Keep Time: Circadian Rhythms and Lung Immunity COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications The chronobiology of human cytokine production Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications Endogenous circadian regulation of pro-inflammatory cytokines and chemokines in the presence of bacterial lipopolysaccharide in humans Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan Clocking in to immunity Circadian control of the immune system Circadian control of lung inflammation in influenza infection Circadian molecular clock in lung pathophysiology Influenza: the mother of all pandemics A local circadian clock calls time on lung inflammation Endocrine regulation of circadian physiology IL-6 and its circadian secretion in humans Shift work and vascular events: systematic review and meta-analysis A randomized placebo controlled trial of ibuprofen for respiratory syncytial virus infection in a bovine model Molecular mimicry of ACTH in SARS -implications for corticosteroid treatment and prophylaxis Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-α, and granulocyte-macrophage colony-stimulating factor in men